- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 13.08 | -12.23 | -10.84 | 169.01 | 1.7 | 41.1 | N/A | - | ||
| 2024/10 | 14.9 | 13.55 | -13.55 | 155.94 | 2.92 | 44.36 | N/A | - | ||
| 2024/9 | 13.12 | -19.71 | -17.3 | 141.04 | 5.03 | 50.79 | 0.69 | - | ||
| 2024/8 | 16.34 | -23.38 | 4.51 | 127.92 | 8.02 | 51.14 | 0.68 | - | ||
| 2024/7 | 21.33 | 58.38 | 36.54 | 111.57 | 8.56 | 51.06 | 0.69 | - | ||
| 2024/6 | 13.47 | -17.16 | 12.22 | 90.24 | 3.54 | 46.01 | 0.68 | - | ||
| 2024/5 | 16.26 | -0.14 | 11.13 | 76.78 | 2.15 | 46.99 | 0.66 | - | ||
| 2024/4 | 16.28 | 12.68 | 15.24 | 60.52 | 0.0 | 44.37 | 0.7 | - | ||
| 2024/3 | 14.45 | 5.93 | -5.06 | 44.23 | -4.65 | 44.23 | 0.8 | - | ||
| 2024/2 | 13.64 | -15.49 | -14.58 | 29.78 | -4.45 | 42.37 | 0.84 | - | ||
| 2024/1 | 16.14 | 28.27 | 6.18 | 16.14 | 6.18 | 43.39 | 0.82 | - | ||
| 2023/12 | 12.58 | -14.2 | -21.15 | 178.77 | -23.44 | 44.49 | 0.62 | - | ||
| 2023/11 | 14.67 | -14.9 | -16.63 | 166.18 | -23.61 | 47.77 | 0.58 | - | ||
| 2023/10 | 17.24 | 8.63 | -23.22 | 151.51 | -24.22 | 48.74 | 0.57 | - | ||
| 2023/9 | 15.87 | 1.46 | -25.41 | 134.28 | -24.35 | 47.12 | 0.56 | - | ||
| 2023/8 | 15.64 | 0.09 | -29.43 | 118.41 | -24.2 | 43.26 | 0.61 | - | ||
| 2023/7 | 15.62 | 30.17 | -33.53 | 102.78 | -23.34 | 42.25 | 0.63 | - | ||
| 2023/6 | 12.0 | -17.97 | -37.1 | 87.15 | -21.17 | 40.76 | 0.72 | - | ||
| 2023/5 | 14.63 | 3.54 | -25.59 | 75.15 | -17.85 | 43.98 | 0.67 | - | ||
| 2023/4 | 14.13 | -7.17 | -28.3 | 60.52 | -15.73 | 45.32 | 0.65 | - | ||
| 2023/3 | 15.22 | -4.69 | -15.99 | 46.39 | -10.97 | 46.39 | 0.71 | - | ||
| 2023/2 | 15.97 | 5.06 | 3.35 | 31.17 | -8.3 | 47.13 | 0.7 | - | ||
| 2023/1 | 15.2 | -4.75 | -18.02 | 15.2 | -18.02 | 48.76 | 0.68 | - | ||
| 2022/12 | 15.96 | -9.28 | 21.86 | 233.51 | -5.21 | 56.01 | 0.57 | - | ||
| 2022/11 | 17.59 | -21.63 | -62.88 | 217.55 | -6.73 | 61.32 | 0.52 | 2021年11月與Genzyme 就被授權之歐洲及美國專利權所生之歐洲與美國權利金爭議達成和解，故於2021年11月認列權利金收入。 | ||
| 2022/10 | 22.45 | 5.54 | 34.31 | 199.95 | 7.58 | 65.88 | 0.49 | - | ||
| 2022/9 | 21.27 | -4.0 | 32.08 | 177.5 | 4.94 | 66.93 | 0.54 | - | ||
| 2022/8 | 22.16 | -5.71 | 1.17 | 156.23 | 2.08 | 64.74 | 0.56 | - | ||
| 2022/7 | 23.5 | 23.18 | 25.86 | 134.07 | 2.23 | 62.25 | 0.58 | - | ||
| 2022/6 | 19.08 | -2.97 | -2.4 | 110.57 | -1.68 | 58.45 | 0.57 | - | ||
| 2022/5 | 19.66 | -0.23 | 3.72 | 91.49 | -1.53 | 57.49 | 0.58 | - | ||
| 2022/4 | 19.71 | 8.78 | -2.84 | 71.82 | -2.88 | 53.28 | 0.63 | - | ||
| 2022/3 | 18.12 | 17.25 | -3.36 | 52.11 | -2.89 | 52.11 | 0.59 | - | ||
| 2022/2 | 15.45 | -16.67 | -1.72 | 34.0 | -2.64 | 47.09 | 0.66 | - | ||
| 2022/1 | 18.54 | 41.58 | -3.4 | 18.54 | -3.4 | 79.04 | 0.39 | - | ||
| 2021/12 | 13.1 | -72.36 | -26.33 | 246.35 | 43.86 | 77.21 | 0.36 | - | ||
| 2021/11 | 47.4 | 183.55 | 191.69 | 233.26 | 52.0 | 80.22 | 0.35 | 與Genzyme 就被授權之歐洲及美國專利權所生之歐洲與美國權利金爭議達成和解，故本月認列權利金收入。 | ||
| 2021/10 | 16.72 | 3.79 | 8.93 | 185.86 | 35.45 | 54.72 | 0.51 | - | ||
| 2021/9 | 16.1 | -26.46 | 3.94 | 169.14 | 38.79 | 56.68 | 0.41 | - | ||
| 2021/8 | 21.9 | 17.28 | 14.72 | 153.04 | 43.87 | 60.12 | 0.39 | - | ||
| 2021/7 | 18.67 | -4.47 | 27.85 | 131.14 | 50.24 | 57.18 | 0.41 | 109年受到疫情影響停工，銷量減少，110年疫情趨緩，銷量增加，致營收增加。 | ||
| 2021/6 | 19.55 | 3.12 | 66.33 | 112.46 | 54.74 | 58.79 | 0.35 | 109年因疫情影響，營收減少，110年因疫情趨緩，營收增加 | ||
| 2021/5 | 18.96 | -6.54 | 109.32 | 92.91 | 52.51 | 57.99 | 0.36 | 109年因疫情影響，營收減少，110年因疫情趨緩，營收增加 | ||
| 2021/4 | 20.29 | 8.2 | 181.42 | 73.96 | 42.59 | 54.76 | 0.38 | 109年受到疫情影響停工，銷量減少，110年疫情趨緩，銷量增加，致營收增加。 | ||
| 2021/3 | 18.75 | 19.24 | 22.78 | 53.67 | 20.18 | 53.67 | 0.53 | - | ||
| 2021/2 | 15.72 | -18.1 | 7.06 | 34.92 | 18.82 | 52.7 | 0.54 | - | ||
| 2021/1 | 19.2 | 7.98 | 30.57 | 19.2 | 30.57 | 53.23 | 0.54 | - | ||
| 2020/12 | 17.78 | 9.41 | 903.0 | 171.24 | -23.11 | 49.37 | 0.45 | 本月營收較同期增加，係108年12月當期調減108年第2季到第4季未收到之權利金收入所致。 | ||
| 2020/11 | 16.25 | 5.89 | -2.59 | 153.46 | -30.54 | 47.09 | 0.47 | - | ||
| 2020/10 | 15.34 | -0.95 | -11.36 | 137.21 | -32.82 | 49.93 | 0.44 | - | ||
| 2020/9 | 15.49 | -18.84 | -17.91 | 121.86 | -34.81 | 49.19 | 0.47 | - | ||
| 2020/8 | 19.09 | 30.7 | -20.95 | 106.37 | -36.71 | 45.45 | 0.51 | - | ||
| 2020/7 | 14.61 | 24.26 | -30.81 | 87.28 | -39.35 | 35.41 | 0.65 | - | ||
| 2020/6 | 11.75 | 29.77 | -41.88 | 72.67 | -40.82 | 28.02 | 1.0 | - | ||
| 2020/5 | 9.06 | 25.63 | -57.3 | 60.92 | -40.61 | 31.53 | 0.89 | 營收較去年同期減少，係因受到疫情影響，銷量減少所致 | ||
| 2020/4 | 7.21 | -52.79 | -65.14 | 51.87 | -36.26 | 37.16 | 0.75 | 營收較上期、去年同期減少，係因受疫情停工影響，銷量減少，以致營收減少 | ||
| 2020/3 | 15.27 | 3.97 | -27.21 | 44.66 | -26.41 | 44.66 | 0.66 | - | ||
| 2020/2 | 14.69 | -0.11 | -18.56 | 29.39 | -25.99 | 31.16 | 0.95 | - | ||
| 2020/1 | 14.7 | 729.44 | -32.18 | 14.7 | -32.18 | 0.0 | N/A | - | ||
| 2019/12 | 1.77 | -89.37 | -90.96 | 222.71 | -8.83 | 0.0 | N/A | 係原合併營收公告數與會計師查核數差異，請參閱109/3/20序號5重訊之說明 |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 16.14 | 2023/1 | 15.2 | 2022/1 | 18.54 | 2021/1 | 19.2 | 2020/1 | 14.7 |
| 2024/2 | 13.64 | 2023/2 | 15.97 | 2022/2 | 15.45 | 2021/2 | 15.72 | 2020/2 | 14.69 |
| 2024/3 | 14.45 | 2023/3 | 15.22 | 2022/3 | 18.12 | 2021/3 | 18.75 | 2020/3 | 15.27 |
| 2024/4 | 16.28 | 2023/4 | 14.13 | 2022/4 | 19.71 | 2021/4 | 20.29 | 2020/4 | 7.21 |
| 2024/5 | 16.26 | 2023/5 | 14.63 | 2022/5 | 19.66 | 2021/5 | 18.96 | 2020/5 | 9.06 |
| 2024/6 | 13.47 | 2023/6 | 12.0 | 2022/6 | 19.08 | 2021/6 | 19.55 | 2020/6 | 11.75 |
| 2024/7 | 21.33 | 2023/7 | 15.62 | 2022/7 | 23.5 | 2021/7 | 18.67 | 2020/7 | 14.61 |
| 2024/8 | 16.34 | 2023/8 | 15.64 | 2022/8 | 22.16 | 2021/8 | 21.9 | 2020/8 | 19.09 |
| 2024/9 | 13.12 | 2023/9 | 15.87 | 2022/9 | 21.27 | 2021/9 | 16.1 | 2020/9 | 15.49 |
| 2024/10 | 14.9 | 2023/10 | 17.24 | 2022/10 | 22.45 | 2021/10 | 16.72 | 2020/10 | 15.34 |
| 2024/11 | 13.08 | 2023/11 | 14.67 | 2022/11 | 17.59 | 2021/11 | 47.4 | 2020/11 | 16.25 |
| N/A | N/A | 2023/12 | 12.58 | 2022/12 | 15.96 | 2021/12 | 13.1 | 2020/12 | 17.78 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
